Generate Biomedicines, Inc. (GENB)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Generate Biomedicines, Inc.’s filings yet. We add companies and filings all the time.
Track GENB and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| FMR LLC | Aug 13, 2026 | $88.09M |
| Capital World Investors | Aug 12, 2026 | $71.12M |
| T. Rowe Price Associates, Inc. | Aug 14, 2026 | $36.38M |
| Norges Bank | Aug 12, 2026 | $35.34M |
| BlackRock, Inc. | Aug 7, 2026 | $28M |
GENB's filings are public. The insight is one click away.
Scrutar's AI reads every GENB filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a GENB filing.
Get an email when GENB files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 17, 2026Source: SEC EDGAR.